Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 9.26%244.52B | 6.47%900.79B | 4.12%209.05B | 3.05%238.87B | 7.36%229.07B | 11.82%223.8B | 13.27%846.08B | 6.76%200.79B | 18.70%231.79B | 16.72%213.37B |
Cost of revenue | 9.71%197.34B | 3.02%725.41B | 1.01%171.49B | -1.73%189.09B | 4.66%184.95B | 8.86%179.87B | 15.21%704.16B | 7.38%169.78B | 20.25%192.43B | 18.89%176.72B |
Gross profit | 7.38%47.18B | 23.58%175.38B | 21.13%37.56B | 26.45%49.77B | 20.39%44.12B | 25.86%43.93B | 4.57%141.92B | 3.48%31.01B | 11.65%39.36B | 7.31%36.65B |
Operating expense | 15.53%35.06B | 9.11%126.52B | 9.73%31.45B | 4.55%32.7B | 11.03%32.03B | 11.68%30.34B | 13.20%115.96B | 8.59%28.66B | 21.06%31.28B | 14.86%28.85B |
Staff costs | 16.78%10.83B | 10.51%38.98B | 14.55%9.92B | 4.73%9.91B | 12.24%9.88B | 11.04%9.27B | 11.30%35.27B | 5.23%8.66B | 20.88%9.47B | 12.50%8.8B |
Selling and administrative expenses | 14.14%8.06B | 2.48%28.86B | 7.60%6.57B | 1.12%7.88B | -0.14%7.34B | 2.27%7.06B | 11.80%28.16B | 0.28%6.11B | 16.49%7.79B | 19.19%7.35B |
-General and administrative expense | 14.14%8.06B | 2.48%28.86B | 7.60%6.57B | 1.12%7.88B | -0.14%7.34B | 2.27%7.06B | 11.80%28.16B | 0.28%6.11B | 16.49%7.79B | 19.19%7.35B |
Depreciation and amortization | 11.38%910M | 24.85%3.44B | 29.17%766M | 2.24%912M | 37.52%942M | 40.14%817M | 25.71%2.75B | 2.42%593M | 63.67%892M | 28.52%685M |
-Depreciation | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Amortization | 11.38%910M | 24.85%3.44B | 29.17%766M | 2.24%912M | 37.52%942M | 40.14%817M | 25.71%2.75B | 2.42%593M | 63.67%892M | 28.52%685M |
Other operating expenses | 15.65%15.26B | 11.00%55.25B | 6.70%14.19B | 6.61%13.99B | 15.47%13.87B | 16.42%13.19B | 14.78%49.77B | 15.72%13.3B | 21.88%13.13B | 13.38%12.01B |
Operating profit | -10.81%12.12B | 88.20%48.86B | 160.65%6.11B | 111.18%17.07B | 55.02%12.09B | 75.68%13.59B | -22.00%25.96B | -34.31%2.34B | -14.15%8.09B | -13.67%7.8B |
Net non-operating interest income (expenses) | -20.12%-806M | -44.94%-2.69B | 5.41%-577M | -51.99%-725M | -80.45%-720M | -80.38%-671M | -31.03%-1.86B | -72.32%-610M | -1.27%-477M | -39.51%-399M |
Non-operating interest income | 188.89%156M | 155.00%561M | 359.68%285M | 173.91%126M | 50.00%96M | 12.50%54M | 17.65%220M | -13.89%62M | 155.42%46M | -37.86%64M |
Non-operating interest expense | 32.69%962M | 56.59%3.25B | 28.27%862M | 62.72%851M | 76.24%816M | 72.62%725M | 29.47%2.08B | 57.75%672M | 34.79%523M | 19.02%463M |
Net investment income | -4.13%928M | 8.36%2.29B | 3.38%306M | 16.67%756M | 6.48%263M | 4.65%968M | 7.41%2.12B | 6.86%296M | 3.51%648M | 68.03%247M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 357.84%3.68B | 354.55%50M | -63.60%804M | 11M | ||||||
Income from associates and other participating interests | 307.06%692M | -238.71%-1.91B | -2,413.46%-3.61B | 26.65%537M | 41.31%992M | 78.95%170M | -39.45%1.38B | -52.73%156M | -11.48%424M | -13.44%702M |
Special income (charges) | 4,107.08%4.75B | -200.07%-1.37B | -135.93%-802M | 72.63%-346M | 37.11%-339M | -88.03%113M | -46.95%1.37B | 203.53%2.23B | -1,111.20%-1.26B | -439.00%-539M |
Less:Restructuring and mergern&acquisition | ---5.45B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Less:Other special charges | 714.16%694M | 145.51%856M | 110.36%284M | -72.63%346M | -37.11%339M | 88.03%-113M | 27.32%-1.88B | -227.09%-2.74B | 1,111.20%1.26B | 439.00%539M |
Less:Write off | ---- | 1.97%518M | ---- | ---- | ---- | ---- | --508M | ---- | ---- | ---- |
Other non-operating income (expenses) | 2.17%329M | 32.26%1.44B | 39.58%670M | 97.09%-15M | 18.46%462M | -56.07%322M | 103.36%1.09B | 81.82%480M | -25,850.00%-515M | 133.53%390M |
Income before tax | 24.33%18.01B | 62.98%50.29B | -56.35%2.14B | 171.82%20.91B | 55.50%12.75B | 44.03%14.49B | -25.53%30.86B | 18.67%4.91B | -24.41%7.69B | -16.12%8.2B |
Income tax | -17.38%3.8B | 70.20%16.13B | 9.22%1.87B | 180.61%5.99B | 55.25%3.67B | 40.85%4.6B | -22.32%9.48B | 3.75%1.71B | -31.94%2.14B | -12.06%2.36B |
Net income | 43.74%14.21B | 59.77%34.16B | -91.55%270M | 168.48%14.92B | 55.61%9.08B | 45.55%9.89B | -26.87%21.38B | 28.69%3.19B | -21.07%5.56B | -17.66%5.83B |
Net income continuous operations | 43.75%14.21B | 59.78%34.16B | -91.54%270M | 168.45%14.92B | 55.61%9.08B | 45.55%9.89B | -26.88%21.38B | 28.59%3.19B | -21.06%5.56B | -17.66%5.83B |
Noncontrolling interests | -20.30%212M | 18.70%1.13B | -2.60%225M | 155.47%350M | -2.03%289M | -7.96%266M | -8.90%952M | 46.20%231M | -46.48%137M | -11.94%295M |
Net income attributable to the company | 45.52%14B | 61.69%33.03B | -98.51%44M | 168.76%14.57B | 58.72%8.79B | 47.92%9.62B | -27.54%20.43B | 27.51%2.96B | -20.11%5.42B | -17.96%5.54B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 45.52%14B | 61.69%33.03B | -98.51%44M | 168.76%14.57B | 58.72%8.79B | 47.92%9.62B | -27.54%20.43B | 27.51%2.96B | -20.11%5.42B | -17.96%5.54B |
Gross dividend payment | ||||||||||
Basic earnings per share | 45.44%56.49 | 61.67%133.33 | -98.49%0.18 | 168.75%58.83 | 58.68%35.48 | 47.91%38.84 | -27.56%82.47 | 27.37%11.96 | -20.11%21.89 | -17.98%22.36 |
Diluted earnings per share | 45.44%56.49 | 61.67%133.33 | -98.51%0.1776 | 168.75%58.829 | 58.68%35.48 | 47.91%38.84 | -27.56%82.47 | 27.48%11.9585 | -20.11%21.89 | -17.98%22.36 |
Dividend per share | 0 | 12.50%27 | 25.00%15 | 0 | 0.00%12 | 0 | 0.00%24 | 0.00%12 | 0 | 0.00%12 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |